Clinical trials
Phase 1 Tuberculosis, Pulmonary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 2 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Global Alliance for TB Drug Development | 8 |
| Access to Advanced Health Institute (AAHI) | 3 |
| Innovative Medicines for Tuberculosis | 2 |
| Michael Hoelscher | 2 |
| National University Hospital, Singapore | 2 |
| Fourth Affiliated Hospital of Xinjiang Medical University | 1 |
| Johns Hopkins University | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Quratis Inc. | 1 |
| University of Pennsylvania | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis, Pulmonary | 23 |
| Tuberculosis | 17 |
| Lung Diseases | 4 |
| Mycobacterium Infections | 2 |
| Tuberculosis, Multidrug-Resistant | 2 |
| AIDS-Related Opportunistic Infections | 1 |
| Acquired Immunodeficiency Syndrome | 1 |
| Bacterial Infections | 1 |
| HIV Infections | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.